Surgical infection society position on vancomycin-resistant Enterococcus

Archives of Surgery

Volumn 131, Issue 10, 1996, Pages 1061-1068

  Davis, John Mihran ^a   Huycke, Mark M ^b   Wells, Carol L ^c   Bohnen, John M A ^d   Gadaleta, Dominick ^e   Fichtl, Richard E ^f   Barie, Philip S ^a  

^a Medical College ^*  (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; ENTEROCOCCUS; HUMAN; INFECTION CONTROL; OPERATING ROOM; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STAPHYLOCOCCUS;

EID: 0029815718     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430220055013     Document Type: Review

References (80)

1. Murray BE. The life and times of Enterococcus. Clin Microbiol Rev. 1990;3:46-65.
2. Moellering RC. Emergence of Enterococcus as a significant nosocomial pathogen. Clin Infect Dis. 1992;14:1173-1178.
3. Schaberg D. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91(suppl):72S-5S.
4. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet. 1988;1:57-58.
5. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319:157-161.
6. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993; 42:597-599.
7. Uttley AHC, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect. 1989;103:173-181.
8. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993;342:76-79.
9. Hall LMC, Chen HY, Williams RJ. Vancomycin-resistant Enterococcus durans. Lancet. 1992;340:1105.
10. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother. 1993;37:1563-1571.
11. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn 1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol. 1993;175:117-127.
12. Quintiliani R Jr, Courvalin P. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves movement of large genetic elements from chromosome to chromosome. FEMS Microbiol Lett. 1994;119:359-364.
13. Schaberg DR, Zervos MJ. Intergeneric and interspecies gene exchange in gram-positive cocci. Antimicrob Agents Chemother. 1986;30:817-822.
14. Clewell DB. Bacterial sex pheromone-induced plasmid transfer. Cell. 1993;73:9-12.
15. Huycke MM, Gilmore MS, Jett BD, Booth JL. Transfer of pheromone-inducible plasmids between Enterococcus faecalis in the Syrian hamster gastrointestinal tract. J Infect Dis. 1992;166:1188-1191.
16. Dunny G, Craig R, Carron R, Clewell D. Plasmid transfer in Streptococcus faecalis: production of multiple sex pheromones by recipients. Plasmid. 1979;6:454-465.
17. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev. 1994;7:462-478.
18. Leclercq R, Derlot E, Weber M, Duval J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1989;33:10-15.
19. Nicas TI, Wu CYE, Hobbs JN Jr, Preston DA, Allen NE. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother. 1989;33:1121-1124.
20. Handwerger S, Pucci MJ, Kolokathis A. Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228. Antimicrob Agents Chemother. 1990;34:358-360.
21. Quintiliani R Jr, Evers S, Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis. 1993; 167:1220-1223.
22. Gold HS, Unal S, Cercenado E, et al. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecium demonstrates homology with vanB, vanA and vanC genes of enterococci. Antimicrob Agents Chemother. 1993;37:1604-1609.
23. Shlaes DM, Bouvet A, Shlaes JH, Al-Obeid S, Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother. 1989;33:198-203.
24. Dutka-Malen SR, Leclercq R, Coutant V, Duval J, Courvalin P. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob Agents Chemother. 1990;34:1875-1879.
25. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Mircobiol Lett. 1992;93:195-198.
26. Clewell DB, Flannagan SE. The conjugative transposons of gram-positive bacteria. In: Clewell DB, ed. Bacterial Conjugation. New York, NY: Plenum Press; 1993:369-393.
27. Klare I, Heier H, Claus H, Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett. 1993;106:23-30.
28. Brisson-Noel A, Dutka-Malen S, Molinas C, Leclercq R, Courvalin P. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147. Antimicrob Agents Chemother. 1990;34:924-927.
29. Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis. 1986;153:1075-1083.
30. Hussain Z, Kuhn M, Lannigan R, Austin TW. Microbiological investigation of an outbreak of bacteraemia due to Streptococcus faecalis in an intensive care unit. J Hosp Infect. 1988;12:263-271.
31. Huycke MM, Spiegel CA, Gilmore MS. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 1991;35:1626-1634.
32. Murray BE, Singh KV, Markowitz SM, et al. Evidence for clonal spread of a single strain of β-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis. 1991;163:780-785.
33. Murray BE, Lopardo HA, Rubeglio EA, Frosolono M, Singh KV. Intrahospital spread of a single gentamicin-resistant, β-lactamase-producing strain of Enterococcus faecalis in Argentina. Antimicrob Agents Chemother. 1992;36:230-232.
34. Rhinehart E, Smith NE, Wennersten C, et al. Rapid dissemination of β-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990;26:1814-1818.
35. Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med. 1992;116:285-292.
36. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994;38:1363-1367.
37. Woodford N, Morrison D, Johnson AP, Briant V, George RC, Cookson B. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31:653-658.
38. Chow JW, Kuritza A, Shales DM, Green M, Sahm DF, Zervos MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol. 1993;31:1609-1611.
39. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31:1280-1285.
40. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium transferable vanB class vancomycin resistance. J Clin Microbiol. 1994;32:1148-1153.
41. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 1992;13:195-200.
42. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117:112-116.
43. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother. 1993;37:2311-2317.
44. Noskin GA, Till M, Patterson BK, Clarke JT, Warren JR. High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis. 1991;164:1212-1215.
45. Hoge CW, Adams J, Buchman B, Sears SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis. 1991;13:600-605.
46. Matlow AG, Bohnen JMA, Nohr C, Christou N, Meakins J. Pathogenicity of enterococci in a rat model of fecal peritonitis. J Meet Dis. 1989;160:142-144.
47. Montravers P, Andremont A, Massias L, Carbon C. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis. 1994;169:821-830.
48. Hospital Infection Control Practices Advisory Committee (HICPAC). Recomendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol. 1995;16:105-113.
49. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992;13:700-705.
50. Wells CL, Juni BA, Cameron SB, Mason KR, Ferrieri P, Rhame FR. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococcal infections in hospitalized medical/surgical patients, Clin Infect Dis. 1995;4:204-210.
51. Gadaleta, D, Woltman, J, Armellino, D. Tortaloni, A, Farber, B, Multiply-resistant enterococcal infections in surgical patients. Presented at the 14th Annual Meeting of the Surgical Infection Society; April 1994; Toronto, Ontario.
52. Barie PS, Christou NV, Dellinger EP, Rout WR, Stone HH, Waymack JP. Pathogenicity of the Enterococcus in surgical infections. Ann Surg. 1990;212:155-159.
53. Standiford HC. Tetracyclines and chioramphenicol. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infections Diseases. 4th ed. New York, NY: Churchill Livingstone Inc; 1995:306-316.
54. Hirschman AZ, Meyers BR, Bradbury K, Mehl R, Gendelman S, Kimmelblatt B. Use of antimicrobial agents in a university teaching hospital: evolution of a comprehensive control program. Arch Intern Med. 1988;146:2001-2007.
55. Freedy HR, Simonelli RJ. Concurrent monitoring of third generation cephalosporins. Am J Hosp Pharm. 1986;43:140-141.
56. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis. 1987;9:1065-1078.
57. Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol. 1990;28:2064-2068.
58. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987;316:927-931.
59. Kaye D. Enterococci: biologic epidemiologic characteristics and in vitro susceptibility. Arch Intern Med. 1982;142:2006-2009.
60. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev. 1994;7:462-478.
61. Bingen EH, Denamur E, Lambert-Zechovsky NY, Elion J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faeclum in a pediatric hospital. J Clin Microbiol. 1991;29:1888-1892.
62. Berkelman RL, Bryan RT, Osterholm MT, LeDuc J, Hughes JM. Infectious disease surveillance: a crumbling foundation. Science. 1994;264:368-370.
63. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 1994;34:515-528.
64. Salzman TC, Clark JJ, Lemm L. Hand contamination of personnel as a mechanism of cross-infection in nosocomial infections with antibiotic-resistant Escherichia coli and Klebsiella-Aerobacter. Antimicrob Agents Chemother. 1967;2:97-100.
65. Rammelkamp CH, Mortimer EA, Wolinsky E. Transmission of streptococcal and staphylococcal infections. Ann intern Med. 1964;60:753-758.
66. Rotter ML. Hygenic hand disinfection. Infect Control. 1984;5:18-22.
67. Murray BE. Can antibiotic resistance be controlled? N Engl J Med. 1994;330: 1229-1230.
68. Brown RE, Palmer CS, Simpson K. Estimate of Identifiable Costs of Tuberculosis in the United States in 1991. Washington, DC: Battelle Medical Technology Assessment and Policy Research Center; 1993.
69. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121:182-205.
70. Garner JS, Simmons BS. Guidelines for handwashing and hospital environmental control. Infect Control. 1986;7:231-242.
71. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med. 1992;327:88-93.
72. Weinstein RA, Nathan C, Gruensfelder R, Kabins SA. Endemic and aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis. 1980;141:338-345.
73. Leciair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med. 1987;317:329-334.
74. Goldmann D, Larson E. Hand-washing and nosocomial infections. N Engl J Meet. 1992;327:120-122.
75. Jarvis WR. Handwashing: the Semmelweis lesson forgotten? Lancet 1994; 344:1311-1312.
76. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing, Ann Intern Med. 1988;109:394-398.
77. Tomasz A. Multiple antibiotic-resistant pathogenic bacteria. N Engl J Med. 1994; 330:1247-1252.
78. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother. 1994;34:507-514.
79. American Hospital Association. The AHA Guide to the Health Care Field. Chicago, III: American Hospital Association; 1993.
80. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. MMWR Morb Mortal Wkly Rep. 1995;44:1-13.